Dargen 40 Injection
Marketer
Lupin Ltd
Salt Composition
Darbepoetin alfa (40mcg)
Overview Dargen 40 Injection
Erythropoiesis-stimulating Dargen 40 Injection treats anemia stemming from chronic kidney disease or chemotherapy. Its mechanism involves bone marrow stimulation for increased red blood cell production. Administered under medical supervision, Dargen 40 requires cautious use due to potential serious adverse effects. Expert medical guidance is crucial; patients must strictly adhere to their physician's instructions. Common side effects encompass abdominal discomfort, hypertension, skin rashes, injection site soreness, dyspnea, cough, and peripheral swelling. Report symptoms of severe hypertension—intense headache, visual disturbances, nausea, vomiting, or convulsions—immediately. Regular blood tests monitoring electrolyte (potassium) levels, hemoglobin, and blood cell counts are typically conducted. Discontinue use and seek medical attention for sudden shortness of breath or skin eruptions. Prior to treatment, disclose any pre-existing heart conditions, hypertension, seizure history, or stroke. Consult your physician regarding pregnancy, breastfeeding, or pregnancy intentions to assess the medication's suitability.
Uses of Dargen 40 Injection
Managing Anemia in Chronic Kidney Disease Patients | Addressing Chemotherapy-Induced Anemia
Major Benefits of Dargen 40 Injection:
This medication will be administered by your healthcare provider; self-medication is strongly discouraged.
Common Side effects of Dargen 40 Injection:
- Abdominal pain
- High blood pressure
- Rash
- Injection site pain
- Breathlessness
- Cough
- Peripheral edema
- Procedural hypotension (low blood pressure)
- Convulsion
- Thromboembolism
How to use Dargen 40 Injection:
This medication will be administered by your healthcare provider; self-medication is strongly discouraged.
How Dargen 40 Injection works:
Dargen 40 Injection is an erythropoietin-based medication that boosts red blood cell production. It acts by stimulating the bone marrow's creation of red blood cells, a process vital for oxygen transport within the body.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Dargen 40 Injection may pose safety risks; a physician's advice is recommended.
PregnancyCONSULT YOUR DOCTOR
The use of Dargen 40 Injection during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Dargen 40 Injection while breastfeeding is likely inadvisable. Preliminary human studies indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Dargen 40 Injection.
KidneySAFE IF PRESCRIBED
Dargen 40 Injection poses no safety concerns for patients with renal impairment; no dosage modification is necessary.
LiverCAUTION
Exercise caution when administering Dargen 40 Injection to individuals with hepatic impairment; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Dargen 40 Injection :
Should you forget a Dargen 40 Injection, administer it at your earliest convenience. However, if your next scheduled dose is imminent, omit the missed injection and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Dargen 40 Injection
| Label | Value |
|---|---|
| Chemical Type | Amino Acid and Peptide Analogs |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Action Class | Erythropoietin-stimulating drug |




